Clinical trial
Reverse Phenotyping Core (RPC)
NCT03632239 is registered in ClinicalTrials.gov with National Human Genome Research Institute (NHGRI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Reverse Phenotyping Core (RPC)
- Lead sponsor
- National Human Genome Research Institute (NHGRI)
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- January 23, 2020
- Completion date
- December 29, 2099
- Enrollment
- 1,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
harboring of unexpected genetic variant